Magnetic Resonance Imaging of Tumors with the Use of Iron Oxide Magnetic Nanoparticles as a Contrast Agent

Bull Exp Biol Med. 2017 Apr;162(6):808-811. doi: 10.1007/s10517-017-3718-x. Epub 2017 Apr 21.

Abstract

We studied the possibility of using BSA-coated magnetic iron oxide nanoparticles for magnetic resonance imaging diagnosis of C6 glioblastoma, 4T1 mammary adenocarcinoma, and RS-1 hepatic mucous carcinoma. In all three cases, magnetic nanoparticles accumulated in the tumor and its large vessels. Magnetic resonance imaging with contrast agent allows visualization of the tumor tissue and its vascularization.

Keywords: cancer; magnetic nanoparticles; magnetic resonance imaging (MRI); tumor; tumor vessels.

MeSH terms

  • Adenocarcinoma / diagnostic imaging*
  • Adenocarcinoma / metabolism
  • Adenocarcinoma, Mucinous / diagnostic imaging*
  • Adenocarcinoma, Mucinous / metabolism
  • Animals
  • Brain Neoplasms / diagnostic imaging*
  • Brain Neoplasms / metabolism
  • Cell Line, Tumor
  • Contrast Media / chemistry
  • Contrast Media / pharmacokinetics*
  • Female
  • Ferric Compounds / administration & dosage
  • Ferric Compounds / chemistry
  • Glioma / diagnostic imaging*
  • Glioma / metabolism
  • Injections, Subcutaneous
  • Liver Neoplasms / diagnostic imaging*
  • Liver Neoplasms / metabolism
  • Magnetic Resonance Imaging / methods
  • Magnetite Nanoparticles / administration & dosage*
  • Mammary Neoplasms, Experimental / diagnostic imaging*
  • Mammary Neoplasms, Experimental / metabolism
  • Mice
  • Mice, Inbred BALB C
  • Rats
  • Rats, Wistar

Substances

  • Contrast Media
  • Ferric Compounds
  • Magnetite Nanoparticles
  • ferric oxide